Globus Medical (GMED) Revenue & Revenue Breakdown
Globus Medical Revenue Highlights
Latest Revenue (Y)
$2.52B
Latest Revenue (Q)
$598.12M
Main Segment (Y)
Spine
Main Geography (Y)
Non Us
Globus Medical Revenue by Period
Globus Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $2.52B | 60.62% |
| 2023-12-31 | $1.57B | 53.34% |
| 2022-12-31 | $1.02B | 6.76% |
| 2021-12-31 | $958.10M | 21.43% |
| 2020-12-31 | $789.04M | 0.47% |
| 2019-12-31 | $785.37M | 10.15% |
| 2018-12-31 | $712.97M | 12.11% |
| 2017-12-31 | $635.98M | 12.76% |
| 2016-12-31 | $563.99M | 3.53% |
| 2015-12-31 | $544.75M | 14.84% |
| 2014-12-31 | $474.37M | 9.19% |
| 2013-12-31 | $434.46M | 12.56% |
| 2012-12-31 | $385.99M | 16.45% |
| 2011-12-31 | $331.48M | 15.02% |
| 2010-12-31 | $288.19M | 13.31% |
| 2009-12-31 | $254.34M | - |
Globus Medical generated $2.52B in revenue during NA 2024, up 60.62% compared to the previous quarter, and up 320.79% compared to the same period a year ago.
Globus Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $598.12M | -9.00% |
| 2024-12-31 | $657.29M | 5.05% |
| 2024-09-30 | $625.71M | -0.63% |
| 2024-06-30 | $629.69M | 3.80% |
| 2024-03-31 | $606.67M | -1.60% |
| 2023-12-31 | $616.53M | 60.71% |
| 2023-09-30 | $383.64M | 31.56% |
| 2023-06-30 | $291.62M | 5.39% |
| 2023-03-31 | $276.69M | 0.80% |
| 2022-12-31 | $274.50M | 8.01% |
| 2022-09-30 | $254.15M | -3.60% |
| 2022-06-30 | $263.65M | 14.36% |
| 2022-03-31 | $230.55M | -7.79% |
| 2021-12-31 | $250.02M | 8.84% |
| 2021-09-30 | $229.72M | -8.48% |
| 2021-06-30 | $251.02M | 10.41% |
| 2021-03-31 | $227.34M | -2.61% |
| 2020-12-31 | $233.44M | 8.03% |
| 2020-09-30 | $216.10M | 45.11% |
| 2020-06-30 | $148.92M | -21.86% |
| 2020-03-31 | $190.58M | -9.96% |
| 2019-12-31 | $211.67M | 7.88% |
| 2019-09-30 | $196.22M | 0.86% |
| 2019-06-30 | $194.54M | 6.34% |
| 2019-03-31 | $182.95M | -6.63% |
| 2018-12-31 | $195.94M | 15.78% |
| 2018-09-30 | $169.24M | -2.39% |
| 2018-06-30 | $173.38M | -0.59% |
| 2018-03-31 | $174.41M | -0.92% |
| 2017-12-31 | $176.03M | 16.01% |
| 2017-09-30 | $151.74M | -0.42% |
| 2017-06-30 | $152.39M | -2.19% |
| 2017-03-31 | $155.81M | 2.78% |
| 2016-12-31 | $151.59M | 11.75% |
| 2016-09-30 | $135.65M | -1.34% |
| 2016-06-30 | $137.49M | -1.27% |
| 2016-03-31 | $139.26M | -2.33% |
| 2015-12-31 | $142.59M | 4.08% |
| 2015-09-30 | $136.99M | 2.56% |
| 2015-06-30 | $133.57M | 1.49% |
| 2015-03-31 | $131.60M | 2.18% |
| 2014-12-31 | $128.80M | 9.35% |
| 2014-09-30 | $117.79M | 3.71% |
| 2014-06-30 | $113.57M | -0.56% |
| 2014-03-31 | $114.21M | -0.90% |
| 2013-12-31 | $115.25M | 7.52% |
| 2013-09-30 | $107.19M | 0.17% |
| 2013-06-30 | $107.01M | 1.90% |
| 2013-03-31 | $105.02M | 4.46% |
| 2012-12-31 | $100.54M | 6.09% |
| 2012-09-30 | $94.76M | -1.26% |
| 2012-06-30 | $95.98M | 1.33% |
| 2012-03-31 | $94.72M | 7.64% |
| 2011-12-31 | $87.99M | 4.42% |
| 2011-09-30 | $84.27M | 4.12% |
| 2011-06-30 | $80.94M | 3.39% |
| 2011-03-31 | $78.28M | - |
Globus Medical generated $598.12M in revenue during Q1 2025, up -9.00% compared to the previous quarter, and up 97.01% compared to the same period a year ago.
Globus Medical Revenue Breakdown
Globus Medical Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Emerging Technology | $154.00M | $120.22M | $96.14M | $81.32M | $40.60M |
| Spine | $2.37B | $1.45B | $926.70M | $876.78M | $748.45M |
Globus Medical's latest annual revenue breakdown by segment (product or service), as of Dec 24: Spine (93.89%), and Emerging Technology (6.11%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emerging Technology | $35.16M | $22.19M | $83.73M | $38.30M | $31.97M | $32.71M | $27.66M | $34.76M | $25.08M | $29.50M | $24.09M | $29.41M | $13.15M | $25.40M | $20.24M | $20.75M | $14.93M | $18.08M | $9.04M | $5.44M |
| Spine | $710.18M | $575.93M | $1.20B | $587.40M | $574.70M | $592.34M | $347.46M | $256.86M | $251.61M | $245.00M | $230.06M | $234.24M | $217.40M | $224.62M | $209.48M | $230.26M | $212.42M | $215.36M | $207.06M | $143.48M |
Globus Medical's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Spine (95.28%), and Emerging Technology (4.72%).
Globus Medical Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Non Us | $519.29M | $288.71M | $150.90M | $138.53M | $124.59M |
| U | - | - | $871.94M | $819.57M | $664.45M |
Globus Medical's latest annual revenue breakdown by geography, as of Dec 24: Non Us (100.00%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non Us | $144.56M | $114.26M | $265.63M | $129.92M | $123.74M | $125.69M | $74.32M | $46.13M | $42.57M | $41.27M | $37.12M | $38.37M | $34.15M | $37.06M | $31.55M | $35.90M | $34.03M | $34.70M | $33.99M | $23.77M |
| UNITED STATES | $600.78M | $483.86M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| U | - | - | - | - | - | - | - | $245.49M | $234.12M | $233.23M | $217.02M | $225.28M | $196.40M | $212.96M | $198.17M | $215.12M | $193.32M | $198.75M | $182.10M | $125.15M |
Globus Medical's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (80.61%), and Non Us (19.39%).
Globus Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HSIC | Henry Schein | $12.67B | $3.24B |
| GRFS | Grifols | $6.59B | $1.63B |
| ALGN | Align | $4.00B | $1.01B |
| ATR | AptarGroup | $3.58B | $966.01M |
| BIO | Bio-Rad Laboratories | $2.57B | $651.60M |
| GMED | Globus Medical | $2.52B | $598.12M |
| MASI | Masimo | $2.09B | $370.90M |
| HQY | HealthEquity | $1.20B | $325.83M |
| HALO | Halozyme Therapeutics | $1.02B | $325.72M |
| GH | Guardant Health | $739.02M | $232.09M |